On January 22nd at 4:00 pm, join Mazen Karaman, Director of Platform Management – Cell Therapy, for a presentation on Expedited Cell Therapy QC.
As part of the Disruptive Technologies Transforming Advanced Therapies track, in this presentation, you’ll learn how Resilience:
- Has developed fully automated assay processes: One sample for up to 10 assays
- Allows for a QC release cost reduction up to 50%
- Allows for less than 4 hours of hands-on time
- Provides deep characterization of drug product to enable improved CQA discovery and pipeline development
